COMP <GO>
CE vs NEM // 10Y YIELD & FRED MACRO BETA
Celanese Corporation (NYSE) VS. Newmont Corporation (NYSE) • 15-METRIC TALLY: CE 3
— NEM 11
▲ 10Y YIELD & FRED MACRO BETA LEADER: CE
LAST: $49.30 (+2.03%) • MKT CAP: $5.30B
macro-sensitivity
1.16
LAST: $106.61 (-4.64%) • MKT CAP: $116.18B
macro-sensitivity
1.04
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CE VS. NEM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CE | NEM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 20.50% | 41.00% | -20.50 | NEM | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -10.70% | 21.80% | -32.50 | NEM | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 11.9x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 15.14% | 8.02% | +7.12 | CE | /fcf-yield <GO> |
| Operating Margin | -8.20% | 38.10% | -46.30 | NEM | /operating-margins <GO> |
| Net Profit Margin | -12.20% | 31.30% | -43.50 | NEM | /net-margins <GO> |
| Revenue Growth (YoY) | -7.10% | 21.30% | -28.40 | NEM | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.25% | 0.95% | -0.70 | NEM | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.37 | 4.16 | -2.79 | NEM | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 9/9 | -3.00 | NEM | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.40% | 7.00% | +0.40 | NEM | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 64.8 | 36.1 | +28.65 | CE | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 1.16 | 1.04 | +0.12 | CE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 29.0x | 13.8x | +15.20 | NEM | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.30B | $116.18B | -$110.88B | NEM | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CE REV | NEM REV | CE GROSS % | NEM GROSS % | CE FCF | NEM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $9.54B | $22.67B | 20.5% | 44.0% | $803.0M | $9.31B |
| FY 2024 | $10.27B | $18.68B | 22.8% | 44.0% | $531.0M | $5.52B |
| FY 2023 | $10.93B | $11.81B | 44.0% | 44.0% | $1.41B | $2.23B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CE // BETA 1.16
NEM // BETA 1.04